http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109468256-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-115
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-245
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-741
filingDate 2018-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109468256-B
titleOfInvention Probiotic clone strain integrating four-copy F18 pilus operon gene and double-copy F4 pilus operon gene and construction method
abstract The invention relates to the technical field of biology, in particular to a probiotic clone strain integrating a four-copy F18 pilus operon gene and a two-copy F4 pilus operon gene and a construction method thereof, which comprises the following steps: pTargetT- X ::P tet F18 and pTargetT- X ::P tet Constructing a F4 recombinant plasmid; by the construction of a probiotic clone strain integrating a four-copy functional F18 pilus operon gene and a double-copy functional F4 pilus operon gene, a nonresistant four-copy F18 pilus gene and double-copy F4 pilus gene compound integrated clone strain is obtained. The invention has the beneficial effects that: the recombinant strain can effectively improve the adhesion performance to porcine intestinal passage epithelial cells; the orally immunized mice were able to produce immune sera, antibodies to IgG against the F18 fimbriae and against the F4 fimbriae; the serum of the mice can obviously reduce F18 after oral immunization + And F4 + Adherence of the strain to the porcine intestinal continuous cell line IPEC-J2.
priorityDate 2018-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9935767
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582658
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557652
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426152565

Total number of triples: 32.